when will the semaglutide shortage end Wegovy Continues, Leaving Patients On the Weight Loss Drug in Limbo Explainer: What's behind the scramble

Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial

A history of pancreatitis (inflammation of the pancreas)

Both oral semaglutide and injectable GLP-1 medications work through the same biological pathway, but they differ in delivery, convenience, and administration details: 1

More serious side effects of Ozempic and Wegovy include: An increased risk of thyroid cancer Acute pancreatitis Acute kidney injury Hypoglycemia (low blood sugar) Severe stomach problems Allergic reactions Increased heart rate Suicidal ideation Pulmonary aspiration during deep sedation or general anesthesia Availability of Generic Versions Unlike phentermine, for which a lower-cost generic version is available, GLP-1 weight loss drugs (Wegovy, Ozempic) are brand-name only at the present time

In the USA, Wegovy is FDA-approved for chronic weight management, whereas other semaglutide brands like Ozempic are primarily approved for Type 2 Diabetes

2 However, weight loss from Wegovy may indirectly affect your INR over time